Safety and Efficacy Study of Axid Use in Infants Suffering From Gastroesophageal Reflux Disease (GERD)
Public ClinicalTrials.gov record NCT00373334. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double-Blind, Randomized, Parallel, Multicenter Study of Axid (Nizatidine) Oral Solution in the Treatment of Gastroesophageal Reflux Disease (GERD) Symptoms in Infants Age 30 Days-1 Year
Study identification
- NCT ID
- NCT00373334
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Braintree Laboratories
- Industry
- Enrollment
- 138 participants
Conditions and interventions
Conditions
Interventions
- nizatidine (axid) Drug
- placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 30 Days to 1 Year
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2006
- Primary completion
- Jan 31, 2008
- Completion
- Jan 31, 2008
- Last update posted
- Nov 17, 2009
2006 – 2008
United States locations
- U.S. sites
- 26
- U.S. states
- 14
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Hot Springs | Arkansas | 71913 | — |
| Not listed | Jonesboro | Arkansas | 72401 | — |
| Not listed | Little Rock | Arkansas | 72205 | — |
| Not listed | Little Rock | Arkansas | 72211 | — |
| Not listed | Searcy | Arkansas | — | — |
| Not listed | Madiera | California | — | — |
| Not listed | Centennial | Colorado | 80112 | — |
| Not listed | Orlando | Florida | — | — |
| Not listed | Panama City | Florida | 32405 | — |
| Not listed | Tampa | Florida | 33603 | — |
| Not listed | Tifton | Georgia | — | — |
| Not listed | Owensboro | Kentucky | 42303 | — |
| Not listed | Shreveport | Louisiana | 71105 | — |
| Not listed | Lincoln | Nebraska | 68505 | — |
| Not listed | Bismarck | North Dakota | 58501 | — |
| Not listed | Fargo | North Dakota | 58103 | — |
| Not listed | Fairfield | Ohio | 45014 | — |
| Not listed | Mason | Ohio | 45040 | — |
| Not listed | Hershey | Pennsylvania | — | — |
| Not listed | Pittsburgh | Pennsylvania | 15202 | — |
| Not listed | Clarksville | Tennessee | 37043 | — |
| Not listed | Houston | Texas | 77004 | — |
| Not listed | Missouri City | Texas | 77495 | — |
| Not listed | Temple | Texas | 76502 | — |
| Not listed | Ogden | Utah | 84405 | — |
| Not listed | South Jordan | Utah | 84095 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00373334, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 17, 2009 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00373334 live on ClinicalTrials.gov.